单位(元)汇添富国证生物医药ETF(159839)资产负债表 |
报告期 |
2024/6/30 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
资产 |
银行存款 |
5,399,505 |
3,509,731 |
8,052,546 |
3,293,307 |
结算备付金 |
185,909 |
156,917 |
484,790 |
436,050 |
存出保证金 |
28,109 |
54,632 |
46,160 |
48,911 |
交易性金融资产 |
454,803,918 |
540,261,450 |
684,984,011 |
451,571,581 |
其中:股票投资 |
454,803,918 |
540,261,450 |
684,984,011 |
451,571,581 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
120,458 |
4,150,860 |
42,003 |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
7,057 |
- |
- |
资产总计 |
460,537,898 |
548,140,648 |
693,609,510 |
455,349,849 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
2,539,528 |
4,768,382 |
4,658,347 |
556,503 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
194,013 |
225,817 |
278,740 |
194,875 |
应付托管费 |
38,803 |
45,163 |
55,748 |
38,975 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
104 |
637 |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
194,475 |
303,483 |
366,022 |
357,157 |
负债合计 |
2,966,923 |
5,343,483 |
5,358,858 |
1,147,510 |
所有者权益 |
实收基金 |
1,443,735,165 |
1,221,735,165 |
1,568,235,165 |
809,235,165 |
未分配利润 |
-986,164,189 |
-678,938,001 |
-879,984,512 |
-355,032,826 |
所有者权益合计 |
457,570,976 |
542,797,164 |
688,250,653 |
454,202,339 |
负债和所有者权益总计 |
460,537,898 |
548,140,648 |
693,609,510 |
455,349,849 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。